Company intelligence / Profile preview

Mevion Medical Systems

Littleton, Massachusetts, United States

Ownership: Private
Employees: ~91
Development stage: Other

Overview

Mevion's proton therapy systems (notably MEVION S250i and MEVION S250-FIT) are FDA-cleared and commercially deployed, providing highly precise, advanced, and accessible proton therapy for cancer patients globally. Early pre-clinical results in FLASH proton therapy demonstrate ultra-high dose rate capabilities and promise for reduced side effects, but clinical data for FLASH are not yet available[2][4].

Therapeutic areas: Oncology
Modalities: Device
Industry: Therapeutic Medical Devices

Partnerships

RaySearch Laboratories (software integration, treatment planning)Leo Cancer Care (upright patient positioning/ultra-compact proton therapy development)

Beyond the preview

Go deeper on Mevion Medical Systems.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mevion Medical Systems.

Explore the full profile